胚系遗传因素影响真性红细胞增多症干扰素-α治疗的结局
在PROUD-PV和CONTINUATION-PV研究中,122例接受罗培干扰素α-2b治疗的真性红细胞增多症患者中,全基因组关联分析未发现与血液学或分子学应答在全基因组统计显著性水平相关的位点;IFNL4位点靶向分析显示该位点功能二倍型与分子学应答显著相关(P=3.91×10⁻⁴,OR=10.80,95%CI 2.39-69.97),而与血液学应答无关联。
要点
- 全基因组关联分析未发现与干扰素-α治疗后血液学或分子学应答在全基因组统计显著性水平相关的常见胚系多态性。
- IFNL4功能二倍型与分子学应答显著相关(P=3.91×10⁻⁴,OR=10.80,95%CI 2.39-69.97)。
- IFNL4多态性与血液学应答无关联。
核心结论
- IFNL4功能二倍型与真性红细胞增多症患者干扰素-α治疗后的分子学应答显著相关,而与血液学应答无关联。
- 基于IFNL4功能状态对患者进行分层可能有助于优化干扰素-α治疗期间的患者管理。
研究设计与样本
- 研究纳入PROUD-PV和CONTINUATION-PV研究中接受罗培干扰素α-2b治疗的真性红细胞增多症患者共122例。
- 采用全基因组关联分析,利用36个月随访期间的血液学应答和分子学应答纵向数据。
- 针对IFNL4位点进行靶向关联分析,该位点包括蛋白编码变异rs368234815/rs117648444。
主要发现
- 全基因组关联分析未发现与血液学应答或分子学应答在全基因组统计显著性水平相关的关联。
- IFNL4多态性与血液学应答无关联。
- IFNL4功能二倍型(单倍型对,包括蛋白编码变异rs368234815/rs117648444)对分子学应答有统计学显著影响(P=3.91×10⁻⁴;OR=10.80;95%CI 2.39-69.97),表现为根据IFNL4二倍型状态不同JAK2V617F突变负荷变化存在差异。
关键数值与推荐
- IFNL4功能二倍型与分子学应答的关联:P=3.91×10⁻⁴,OR=10.80,95%CI 2.39-69.97。
临床怎么用
- 作者认为,基于IFNL4功能状态对真性红细胞增多症患者进行分层可能有助于优化干扰素-α治疗期间的患者管理。
局限性
- 全基因组关联分析未发现与血液学应答或分子学应答在全基因组统计显著性水平相关的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interferon-α (IFN-α)-based treatments can induce hematologic and molecular responses (HRs and MRs, respectively) in polycythemia vera (PV); however, patients do not respond equally. Germline genetic factors have been implicated in differential drug responses. We addressed the effect of common germline polymorphisms on HR and MR after treatment of PV in the PROUD-PV and CONTINUATION-PV studies in a total of 122 patients who received ropeginterferon alfa-2b. Genome-wide association studies using longitudinal data on HR and MR over a 36-month follow-up did not reveal any associations at the level of genome-wide statistical significance. Furthermore, we performed targeted association analyses at the interferon lambda 4 (IFNL4) locus, well known for its role in hepatitis C viral clearance and recently reported to influence HR during treatment of myeloproliferative neoplasms. We did not observe any association of IFNL4 polymorphisms with HR in our study cohort; however, we demonstrated a statistically significant effect of the functionally causative IFNL4 diplotype (haplotype pair, including the protein-coding variants rs368234815/rs117648444) on MR (P = 3.91 × 10-4; odds ratio, 10.80; 95% confidence interval, 2.39-69.97) as reflected in differential JAK2V617F mutational burden changes according to IFNL4 diplotype status. Stratification of patients with PV based on IFNL4 functionality may allow for optimizing patient management during IFN-α-based therapy.
引用
- Jäger R, Gisslinger H, Fuchs E, et al. Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera. Blood. 2021. PMID: 32814349. doi:10.1182/blood.2020005792
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。